財務とマーケティングのジャーナル

抽象的な

Announcement - 2021

Alireza Hydari

Growing prevalence of respiratory diseases due to the increasing population and pathogens in the environment has been the key aspect for motivating the respiratory disease market globally. Pharmaceutical companies have been developing new bio-based drugs in amalgamation with bio-technology which promises massive growth opportunities along with sustainable development for respiratory disease market over the next decade. Every year the usage of Respiratory devices is on high rise and the market is growing exponentially to meet the demand. With the aim of accelerating the importance of Respiratory Disease, Meetings International is organizing 2nd International Conference on Respiratory Disease & Care during April 19-20, 2021 in Berlin, Germany with the theme ?Optimizing Research Strategies for Lung Disorder Treatments?. Scientific session includes Pathogenesis of COPD, Drugs & Diagnostic Evolution of COPD, Pulmonary Infections & Treatment, Asthma Immunology & Medication, Immunotherapy & Transplantation, Lungs Disease & Their Cause, Environmental & Occupational Lung Disease, Chronic Respiratory Diseases, Respiratory Pharmacology & Care, Acute Respiratory Distress Syndrome, Targeted Therapy for Lungs Cancer, Cystic Fibrosis. Respiratory Care Meetings embraces with Keynote Session, Oral Session, Poster Session, Young Researchers Session and Exhibitor Session.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。